Combined therapy with a sulfonylurea plus evening insulin: Safe, reliable, and becoming routine

Hormone and Metabolic Research

Volumn 28, Issue 9, 1996, Pages 430-433

  Riddle, M C ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Combined; Glomepiride; Insulin; Sulfonylurea; Therapy

Indexed keywords

GLIMEPIRIDE; GLUCOSE; INSULIN; SULFONYLUREA DERIVATIVE;

CHRONOPHARMACOLOGY; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0029853138     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979832     Document Type: Conference Paper

References (30)

1. Bailey, T. S., N. H. E. Mezitis: Combination therapy with insulin and sulfonylureas for type II diabetes. Diabetes Care 13: 687-695 (1990)
2. Beck-Nielsen, H., O. Pedersen, H. O. Lindskow: Increased insulin sensitivity and cellular insulin binding in obese diabetics following treatment with glibenclamide. Acta Endocrinol. 90: 451-462 (1979)
3. Chow, C.-C., L. W. W. Tsang, J. P. Sorensen, C. S. Cockram: Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients. Diabetes Care 18: 307-314 (1995)
4. Cusi, K., G. R. Cunningham, J. P. Comstock: Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM. Diabetes Care 18: 843-851 (1995)
5. The Diabetes Control and Complications Trial Study Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Eng. J. Med. 329: 977-986 (1993)
6. Feldman, J. M., H. E. Lebovitz: Appraisal of the extrapancreatic actions of sulfonylureas. Arch. Intern. Med. 123: 314-322 (1969)
7. Genuth, S.: Insulin use in NIDDM. Diabetes Care 13: 1240-1264 (1990)
8. Groop, L. C., P.-H. Groop, S. Stenman: Combined insulin-sulfonylurea therapy in treatment of NIDDM. Diabetes Care 13 (Suppl. 3): 47-52 (1990)
9. Grunberger, G., J. Ryan, P. Gorden: Sulfonylureas do not affect insulin binding or glycemic control in insulin-dependent diabetics. Diabetes 31: 890-896 (1982)
10. Hadden, D. R., A. L. T. Blair, E. A. Wilson, D. McC. Boyle, A. B. Atkinson, A. L. Kennedy, K. D. Buchanan, J. D. Merrett, D. A. D. Montgomery, J. A. Weaver: Natural history of diabetes presenting age 40-69 years: a prospective study of the influence of intensive dietary therapy. Quart. J. Med. 59: 579-598 (1986)
11. Halimi, S., P. Corticelli, P. Y. Benhamou: Combination of insulin and sulfonylureas: a literature review. Am. J. Med. 90 (Suppl. 6A): 83S-86S (1991)
12. Klein, R.: Hyperglycemia and microvascular macrovascular disease in diabetes. Diabetes Care 18: 258-268 (1995)
13. Landstedt-Hallin, L., U. Adamson, P. Arner, J. Bolinder, P.-E. Lins: Comparison of bedtime NPH or preprandial regular insulin combined with glibenclamide in secondary sulfonylurea failure. Diabetes Care 18: 1183-1186 (1995)
14. Lebovitz, H. E., R. Pasmantier: Combination insulin-sulfonylrea therapy. Diabetes Care 13: 667-675 (1990)
15. Peters, A. L., M. D. Davidson: Insulin plus a sulfonylurea agent for treating type 2 diabetes. Ann. Intern. Med. 11: 45-53 (1991)
16. Pugh, J. A., M. L. Wagner, J. Sawyer, G. Ramirez, M. Tuley, S. J. Friedberg: Is combination sulfonylurea and insulin therapy useful in NIDDM patients? Diabetes Care 15: 953-959 (1992)
17. Raskin, P.: Combination therapy in NIDDM. N. Engl. J. Med. 327: 1453-1454 (1992)
18. Ratzman, K. P., B. Schultz, P. Heinke, W. Besch: Tolbutamide does not alter insulin requirement in type I (insulin-dependent) diabetes. Diabetologia 27: 8-12 (1984)
19. Riddle, M. C.: New tactics for type II diabetes: regimens based on intermediate-acting insulin taken at bedtime. Lancet 1: 192-195 (1985)
20. Riddle, M. C., J. S. Hart, D. J. Bouma, B. E. Phillipson, G. Youker: Efficacy of bedtime NPH insulin with daytime sulfonylurea for a subpopulation of type II diabetes mellitus. Diabetes Care 12: 623-629 (1989)
21. Riddle, M. C.: Evening insulin strategy. Diabetes Care 13: 676-686 (1990)
22. Riddle, M., J. Hart, P. Bingham, C. Garrison, P. McDaniel: Combined therapy for obese type 2 diabetes: suppertime mixed insulin with daytime sulfonylurea. Am. J. Med. Sci. 303: 151-156 (1992)
23. Shank, M. L., S. Del Prato, R. A. DeFronzo: Bedtime insulin/daytime glipizide. Effective therapy for sulfonylurea failures in NIDDM. Diabetes 44: 165-172 (1995)
24. Simonson, D. C., S. Del Prato, P. Castellino, L. Groop, R. A. DeFronzo: Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients. Diabetes 36: 136-146 (1987)
25. Soneru, I. L., L. Agarwal, J. C. Murphy, A. M. Lawrence, C. Abraira: Comparison of morning or bedtime insulin with and without glyburide in secondary sulfonylurea failure. Diabetes Care 16: 896-901 (1993)
26. Taskinen, M.-R., T. Sane, E. Helve, S.-L. Karonen, E. A. Nikkila, H. Yki-Jarvinen: Bedtime insulin for suppression of overnight free-fatty acid, blood glucose, and glucose production in NIDDM. Diabetes 38: 580-588, 1989.
27. Trischitta, V., S. I. Italia, V. Borzi, A. Tribulato, S. Mazzarino, S. Squatrito, R. Vigneri: Low-dose bedtime NPH insulin in treatment of secondary failure ot glyburide. Diabetes Care 12: 582 -585 (1989)
28. UK Prospective Diabetes Study 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin-dependent diabetes followed for three years. Br. Med. J. 310: 83-88 (1995)
29. UK Prospective Diabetes Study 17: The effect of improved metabolic control on complications in NIDDM. Ann. Intern. Med. 124: 136-145 (1996)
30. Yki-Jarvinen, H., M. Kauppila, E. Kujansuu, J. Lahti, P. Seppala, T. Majanen, T. Tulokas, L. Kiskanen, S. Rajala, L. Ryysy, S. Salo, J. Viikari, J. Karjalainen, M.-R. Taskinen: Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus. N. Engl. J. Med. 327: 1426-1433 (1992)